Stay updated on Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now shows a new site revision v3.6.6 replacing the prior v3.6.5, indicating a software update to the page's history interface.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe study history now includes a new revision entry (v3.6.5), updating the record from the previous revision (v3.6.4).SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history, replacing the previous revision (v3.6.3) to reflect an update in the record.SummaryDifference0.1%

- Check71 days agoChange DetectedA new revision entry (v3.6.3) was added to the study record history, signaling an updated version of the record, while the previous revision (v3.6.2) was removed from the list.SummaryDifference0.1%

- Check78 days agoChange DetectedA new study record revision v3.6.2 has been added to the history, updating the version history for the trial and replacing the previous v3.6.0 entry.SummaryDifference0.1%

- Check92 days agoChange DetectedThe history section now includes the added items 'Check who can join' and 'Find Contact Information', and the revision label updates to v3.6.0, replacing v3.5.5.SummaryDifference0.6%

Stay in the know with updates to Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Ruxolitinib in Higher-risk MDS/MPN Clinical Trial page.